Improved growth during the first year of monthly intravenous pamidronate therapy in prepubertal patients with osteogenesis imperfecta

被引：0
|
作者：
Heino, Terhi J. [1 ,2 ,3 ]
Astrom, Eva [1 ,2 ]
Savendahl, Lars [1 ,2 ]
Soderhall, Stefan [1 ,2 ]
机构：
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Women & Child Hlth, Stockholm, Sweden
[2] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden
[3] Univ Turku, Orthopaed Res Unit, Turku, Finland
来源：
HORMONE RESEARCH | 2009年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [1] Intravenous Pamidronate Treatment Improves Growth in Prepubertal Osteogenesis Imperfecta Patients
    Heino, Terhi J.
    Astrom, Eva
    Laurencikas, Evaldas
    Savendahl, Lars
    Soderhall, Stefan
    HORMONE RESEARCH IN PAEDIATRICS, 2011, 75 (05): : 354 - 361
  • [2] Monthly intravenous pamidronate is a safe and efficacious treatment for patients with osteogenesis imperfecta.
    Fujiwara, I
    Ogawa, E
    Igarashi, Y
    Kojima, K
    Katsushima, Y
    Iinuma, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S379 - S379
  • [3] Effects of cyclical intravenous pamidronate therapy on bone markers in pediatric patients with osteogenesis imperfecta
    Campos, Moema L.
    Rorato, Marilia G.
    Gameleira, Kallianna P.
    Vilaca, Renata D.
    Bezerra, Ana Cristina A.
    Cruz, Catia B.
    Castro, Luiz Claudio G.
    HORMONE RESEARCH, 2009, 72 : 80 - 80
  • [4] Response to Pamidronate Therapy and Pharmacogenetics in Patients with Osteogenesis Imperfecta
    Selveindran, Nalini M.
    Hong, Janet Y. H.
    Nawawi, Nadiah Mohd
    Murad, Nor Azian Abdul
    Jamal, Rahman
    Latiff, Zarina Abdul
    Abd Aziz, Bilkis Banu
    Zakaria, Syed Zulkifli Syed
    Zain, Fuziah Md
    Rasat, Rahmah
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 197 - 197
  • [5] Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta
    Lowing, Kristina
    Astrom, Eva
    Oscarsson, Katarina Allbrink
    Soderhall, Stefan
    Eliasson, Ann-Christin
    ACTA PAEDIATRICA, 2007, 96 (08) : 1180 - 1183
  • [6] Osteogenesis imperfecta - Clinical outcomes after a 4-year experience with cyclical intravenous pamidronate therapy
    Castro, L. C.
    Santos, C. C.
    Campos, M. L.
    Gameleira, K. P.
    Rorato, M. G.
    Bezerra, A. C.
    Cruz, C. B.
    BONE, 2009, 45 : S59 - S59
  • [7] Short-term efficacy of monthly pamidronate infusion in patients with osteogenesis imperfecta
    Choi, Jin-Ho
    Shin, Young-Lim
    Yoo, Han-Wook
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (02) : 209 - 212
  • [8] Large Osteoclasts in Pediatric Osteogenesis Imperfecta Patients Receiving Intravenous Pamidronate
    Cheung, Moira S.
    Glorieux, Francis H.
    Rauch, Frank
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (04) : 669 - 674
  • [9] Intravenous pamidronate therapy in osteogenesis imperfecta - Response to treatment and factors influencing outcome
    Bajpai, Anurag
    Kabra, Madhulika
    Gupta, Neerja
    Sharda, Sheetal
    Ghosh, Manju
    JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2007, 27 (02) : 225 - 227
  • [10] Monthly intravenous alendronate treatment can maintain bone strength in osteogenesis imperfecta patients following cyclical pamidronate treatment
    Harada, Daisuke
    Kashiwagi, Hiroko
    Ueyama, Kaoru
    Oriyama, Kyoko
    Hanioka, Yuki
    Sakamoto, Natsuko
    Kondo, Kawai
    Kishimoto, Kanako
    Izui, Masafumi
    Nagamatsu, Yuiko
    Yamada, Hiroyuki
    Tanaka, Hiroyuki
    Namba, Noriyuki
    Seino, Yoshiki
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (11): : 1391 - 1397
12345